Denali Therapeutics Inc. (FRA:4DN)
17.00
+0.41 (2.47%)
At close: Nov 28, 2025
-27.04% (1Y)
| Market Cap | 2.46B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -425.08M |
| Shares Out | n/a |
| EPS (ttm) | -2.48 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 975 |
| Average Volume | 187 |
| Open | 16.65 |
| Previous Close | 16.59 |
| Day's Range | 16.65 - 17.00 |
| 52-Week Range | 10.17 - 24.28 |
| Beta | n/a |
| RSI | 68.62 |
| Earnings Date | Feb 27, 2026 |